ID   DPOG1_HUMAN             Reviewed;        1239 AA.
AC   P54098; Q8NFM2; Q92515;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   07-APR-2021, entry version 214.
DE   RecName: Full=DNA polymerase subunit gamma-1;
DE            EC=2.7.7.7;
DE   AltName: Full=Mitochondrial DNA polymerase catalytic subunit;
DE   AltName: Full=PolG-alpha;
GN   Name=POLG; Synonyms=MDP1, POLG1, POLGA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8884268; DOI=10.1006/geno.1996.0490;
RA   Ropp P.A., Copeland W.C.;
RT   "Cloning and characterization of the human mitochondrial DNA polymerase,
RT   DNA polymerase gamma.";
RL   Genomics 36:449-458(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9034326; DOI=10.1016/s0378-1119(96)00663-4;
RA   Lecrenier N.L., van der Bruggen P., Foury F.;
RT   "Mitochondrial DNA polymerases from yeast to man: a new family of
RT   polymerases.";
RL   Gene 185:147-152(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLN-GLN-55 INS.
RC   TISSUE=Brain;
RA   Watanabe T.K., Shimizu F., Nishino N., Fujiwara T., Kanemoto N., Suzuki M.,
RA   Nakamura Y., Hirai Y., Maekawa H., Takahashi E.;
RL   Submitted (MAR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLN-55 INS; GLN-193;
RP   CYS-546; LYS-662; TRP-1142; GLY-1143; CYS-1146 AND HIS-1236.
RG   NIEHS SNPs program;
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   SUBCELLULAR LOCATION, ASSOCIATION WITH MITOCHONDRIAL DNA, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=18063578; DOI=10.1074/jbc.m708444200;
RA   Bogenhagen D.F., Rousseau D., Burke S.;
RT   "The layered structure of human mitochondrial DNA nucleoids.";
RL   J. Biol. Chem. 283:3665-3675(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [8]
RP   INVOLVEMENT IN SCAE, AND VARIANTS SCAE THR-467; HIS-497 AND SER-748.
RX   PubMed=26942291; DOI=10.1016/j.ajhg.2016.01.009;
RA   Sandford E., Bird T.D., Li J.Z., Burmeister M.;
RT   "PRICKLE2 mutations might not be involved in epilepsy.";
RL   Am. J. Hum. Genet. 98:588-589(2016).
RN   [9]
RP   INTERACTION WITH TTC3.
RX   PubMed=29290964; DOI=10.18632/oncotarget.22476;
RA   Gong Y., Wang X., Shang X., Xiao S.P., Li W., Shang Y., Dou F.;
RT   "Tetratricopeptide repeat domain 3 overexpression tends to form aggregates
RT   and inhibit ubiquitination and degradation of DNA polymerase gamma.";
RL   Oncotarget 8:106475-106485(2017).
RN   [10]
RP   VARIANTS PEOB1 PRO-3; ARG-304; THR-467 AND CYS-955.
RX   PubMed=11431686; DOI=10.1038/90034;
RA   Van Goethem G., Dermaut B., Loefgren A., Martin J.-J., Van Broeckhoven C.;
RT   "Mutation of POLG is associated with progressive external ophthalmoplegia
RT   characterized by mtDNA deletions.";
RL   Nat. Genet. 28:211-212(2001).
RN   [11]
RP   VARIANTS PEOA1 ASP-923; HIS-943; CYS-955; SER-957 AND LEU-1176, AND
RP   VARIANTS PEO ILE-251; LEU-309 AND SER-848.
RX   PubMed=12210792; DOI=10.1002/ana.10278;
RA   Lamantea E., Tiranti V., Bordoni A., Toscano A., Bono F., Servidei S.,
RA   Papadimitriou A., Spelbrink H., Silvestri L., Casari G., Comi G.P.,
RA   Zeviani M.;
RT   "Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of
RT   autosomal dominant or recessive progressive external ophthalmoplegia.";
RL   Ann. Neurol. 52:211-219(2002).
RN   [12]
RP   CHARACTERIZATION OF VARIANT PEOA1 CYS-955.
RX   PubMed=11897778; DOI=10.1074/jbc.c200100200;
RA   Ponamarev M.V., Longley M.J., Nguyen D., Kunkel T.A., Copeland W.C.;
RT   "Active site mutation in DNA polymerase gamma associated with progressive
RT   external ophthalmoplegia causes error-prone DNA synthesis.";
RL   J. Biol. Chem. 277:15225-15228(2002).
RN   [13]
RP   VARIANTS PEOB1 TRP-579; LEU-587; THR-889 AND VAL-1076, AND VARIANT
RP   HIS-1236.
RX   PubMed=12975295; DOI=10.1001/archneur.60.9.1279;
RA   Filosto M., Mancuso M., Nishigaki Y., Pancrudo J., Harati Y., Gooch C.,
RA   Mankodi A., Bayne L., Bonilla E., Shanske S., Hirano M., DiMauro S.;
RT   "Clinical and genetic heterogeneity in progressive external ophthalmoplegia
RT   due to mutations in polymerase gamma.";
RL   Arch. Neurol. 60:1279-1284(2003).
RN   [14]
RP   VARIANTS MTDPS4B ILE-251; LEU-587 AND SER-864.
RX   PubMed=12825077; DOI=10.1038/sj.ejhg.5201002;
RA   Van Goethem G., Schwartz M., Loefgren A., Dermaut B., Van Broeckhoven C.,
RA   Vissing J.;
RT   "Novel POLG mutations in progressive external ophthalmoplegia mimicking
RT   mitochondrial neurogastrointestinal encephalomyopathy.";
RL   Eur. J. Hum. Genet. 11:547-549(2003).
RN   [15]
RP   VARIANT PEOB1 SER-848.
RX   PubMed=12872260; DOI=10.1002/humu.10246;
RA   Van Goethem G., Loefgren A., Dermaut B., Ceuterick C., Martin J.-J.,
RA   Van Broeckhoven C.;
RT   "Digenic progressive external ophthalmoplegia in a sporadic patient:
RT   recessive mutations in POLG and C10orf2/Twinkle.";
RL   Hum. Mutat. 22:175-176(2003).
RN   [16]
RP   VARIANTS PEOB1 ILE-251; ALA-268; ARG-312; THR-467; GLN-562; LEU-587;
RP   PRO-807 AND TYR-932, AND VARIANTS GLY-1143 AND HIS-1236.
RX   PubMed=14635118; DOI=10.1002/humu.9203;
RA   Di Fonzo A., Bordoni A., Crimi M., Sara G., Del Bo R., Bresolin N.,
RA   Comi G.P.;
RT   "POLG mutations in sporadic mitochondrial disorders with multiple mtDNA
RT   deletions.";
RL   Hum. Mutat. 22:498-499(2003).
RN   [17]
RP   VARIANTS PEOB1 TRP-227; ILE-251; ARG-312; VAL-431; THR-467; GLN-1047;
RP   CYS-1096 AND CYS-1104.
RX   PubMed=12707443; DOI=10.1212/01.wnl.0000056088.09408.3c;
RA   Agostino A., Valletta L., Chinnery P.F., Ferrari G., Carrara F.,
RA   Taylor R.W., Schaefer A.M., Turnbull D.M., Tiranti V., Zeviani M.;
RT   "Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external
RT   ophthalmoplegia (PEO).";
RL   Neurology 60:1354-1356(2003).
RN   [18]
RP   VARIANT MERRF THR-467.
RX   PubMed=14694057; DOI=10.1212/01.wnl.0000098997.23471.65;
RA   Van Goethem G., Mercelis R., Loefgren A., Seneca S., Ceuterick C.,
RA   Martin J.-J., Van Broeckhoven C.;
RT   "Patient homozygous for a recessive POLG mutation presents with features of
RT   MERRF.";
RL   Neurology 61:1811-1813(2003).
RN   [19]
RP   VARIANTS PEOB1 PRO-3; ARG-304; THR-467 AND CYS-955, AND VARIANT SANDO
RP   TRP-627.
RX   PubMed=12565911; DOI=10.1016/s0960-8966(02)00216-x;
RA   Van Goethem G., Martin J.-J., Dermaut B., Loefgren A., Wibail A.,
RA   Ververken D., Tack P., Dehaene I., Van Zandijcke M., Moonen M.,
RA   Ceuterick C., De Jonghe P., Van Broeckhoven C.;
RT   "Recessive POLG mutations presenting with sensory and ataxic neuropathy in
RT   compound heterozygote patients with progressive external ophthalmoplegia.";
RL   Neuromuscul. Disord. 13:133-142(2003).
RN   [20]
RP   VARIANT MTDPS4A THR-467.
RX   PubMed=15122711; DOI=10.1002/ana.20079;
RA   Naviaux R.K., Nguyen K.V.;
RT   "POLG mutations associated with Alpers' syndrome and mitochondrial DNA
RT   depletion.";
RL   Ann. Neurol. 55:706-712(2004).
RN   [21]
RP   VARIANTS PEOB1 TRP-227; ILE-251 LEU-309; LEU-587; SER-848 ILE-1106 AND
RP   LEU-1176.
RX   PubMed=15349879; DOI=10.1002/ana.20219;
RA   Lamantea E., Zeviani M.;
RT   "Sequence analysis of familial PEO shows additional mutations associated
RT   with the 752C-->T and 3527C-->T changes in the POLG1 gene.";
RL   Ann. Neurol. 56:454-455(2004).
RN   [22]
RP   VARIANT PEOA1 CYS-831.
RX   PubMed=15534189; DOI=10.1001/archneur.61.11.1777;
RA   Mancuso M., Filosto M., Oh S.J., DiMauro S.;
RT   "A novel polymerase gamma mutation in a family with ophthalmoplegia,
RT   neuropathy, and parkinsonism.";
RL   Arch. Neurol. 61:1777-1779(2004).
RN   [23]
RP   VARIANTS PEOA1 CYS-953 AND CYS-955, AND VARIANTS PEOB1 ASP-468 AND
RP   THR-1105.
RX   PubMed=15351195; DOI=10.1016/s0140-6736(04)16983-3;
RA   Luoma P., Melberg A., Rinne J.O., Kaukonen J.A., Nupponen N.N.,
RA   Chalmers R.M., Oldfors A., Rautakorpi I., Peltonen L., Majamaa K.,
RA   Somer H., Suomalainen A.;
RT   "Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma
RT   mutations: clinical and molecular genetic study.";
RL   Lancet 364:875-882(2004).
RN   [24]
RP   VARIANTS SANDO TYR-932 AND ARG-1051.
RX   PubMed=14745080; DOI=10.1212/wnl.62.2.316;
RA   Mancuso M., Filosto M., Bellan M., Liguori R., Montagna P., Baruzzi A.,
RA   DiMauro S., Carelli V.;
RT   "POLG mutations causing ophthalmoplegia, sensorimotor polyneuropathy,
RT   ataxia, and deafness.";
RL   Neurology 62:316-318(2004).
RN   [25]
RP   VARIANT PEOB1 THR-467, VARIANT SANDO SER-748, AND VARIANT GLY-1143.
RX   PubMed=15477547; DOI=10.1212/01.wnl.0000140494.58732.83;
RA   Van Goethem G., Luoma P., Rantamaeki M., Al-Memar A., Kaakkola S.,
RA   Hackman P., Krahe R., Loefgren A., Martin J.-J., De Jonghe P.,
RA   Suomalainen A., Udd B., Van Broeckhoven C.;
RT   "POLG mutations in neurodegenerative disorders with ataxia but no muscle
RT   involvement.";
RL   Neurology 63:1251-1257(2004).
RN   [26]
RP   VARIANT SANDO SER-748, AND VARIANT GLY-1143.
RX   PubMed=16080118; DOI=10.1086/444548;
RA   Hakonen A.H., Heiskanen S., Juvonen V., Lappalainen I., Luoma P.T.,
RA   Rantamaeki M., Van Goethem G., Loefgren A., Hackman P., Paetau A.,
RA   Kaakkola S., Majamaa K., Varilo T., Udd B., Kaeaeriaeinen H., Bindoff L.A.,
RA   Suomalainen A.;
RT   "Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal
RT   recessive ataxia with ancient European origin.";
RL   Am. J. Hum. Genet. 77:430-441(2005).
RN   [27]
RP   VARIANTS MTDPS4A SER-748 AND SER-848.
RX   PubMed=15929042; DOI=10.1002/ana.20498;
RA   Davidzon G., Mancuso M., Ferraris S., Quinzii C., Hirano M., Peters H.L.,
RA   Kirby D., Thorburn D.R., DiMauro S.;
RT   "POLG mutations and Alpers syndrome.";
RL   Ann. Neurol. 57:921-923(2005).
RN   [28]
RP   VARIANTS MTDPS4A GLY-232; PRO-244; ILE-251 THR-467; LEU-587; SER-748
RP   SER-848 AND PRO-957, AND VARIANT GLY-1143.
RX   PubMed=15689359; DOI=10.1093/brain/awh410;
RA   Ferrari G., Lamantea E., Donati A., Filosto M., Briem E., Carrara F.,
RA   Parini R., Simonati A., Santer R., Zeviani M.;
RT   "Infantile hepatocerebral syndromes associated with mutations in the
RT   mitochondrial DNA polymerase-gammaA.";
RL   Brain 128:723-731(2005).
RN   [29]
RP   VARIANT PEOB1 THR-467, VARIANT SANDO GLN-627, VARIANT HIS-1236,
RP   CHARACTERIZATION OF VARIANT PEOB1 THR-467, AND CHARACTERIZATION OF VARIANT
RP   SANDO GLN-627.
RX   PubMed=15917273; DOI=10.1093/hmg/ddi196;
RA   Luoma P.T., Luo N., Loescher W.N., Farr C.L., Horvath R., Wanschitz J.,
RA   Kiechl S., Kaguni L.S., Suomalainen A.;
RT   "Functional defects due to spacer-region mutations of human mitochondrial
RT   DNA polymerase in a family with an ataxia-myopathy syndrome.";
RL   Hum. Mol. Genet. 14:1907-1920(2005).
RN   [30]
RP   VARIANTS SANDO THR-467; HIS-497 AND SER-748.
RX   PubMed=15824347; DOI=10.1212/01.wnl.0000156516.77696.5a;
RA   Winterthun S., Ferrari G., He L., Taylor R.W., Zeviani M., Turnbull D.M.,
RA   Engelsen B.A., Moen G., Bindoff L.A.;
RT   "Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial
RT   polymerase gamma mutations.";
RL   Neurology 64:1204-1208(2005).
RN   [31]
RP   VARIANTS PEOB1 ARG-737 AND TRP-853.
RX   PubMed=16634032; DOI=10.1002/ana.20831;
RA   Davidzon G., Greene P., Mancuso M., Klos K.J., Ahlskog J.E., Hirano M.,
RA   DiMauro S.;
RT   "Early-onset familial parkinsonism due to POLG mutations.";
RL   Ann. Neurol. 59:859-862(2006).
RN   [32]
RP   VARIANTS PEOB1 LEU-603; TRP-853; CYS-1146 AND ASN-1184.
RX   PubMed=16401742; DOI=10.1001/archneur.63.1.107;
RA   Gonzalez-Vioque E., Blazquez A., Fernandez-Moreira D., Bornstein B.,
RA   Bautista J., Arpa J., Navarro C., Campos Y., Fernandez-Moreno M.A.,
RA   Garesse R., Arenas J., Martin M.A.;
RT   "Association of novel POLG mutations and multiple mitochondrial DNA
RT   deletions with variable clinical phenotypes in a Spanish population.";
RL   Arch. Neurol. 63:107-111(2006).
RN   [33]
RP   VARIANTS PEOB1 HIS-308; TRP-574 AND ARG-648, VARIANT SANDO VAL-517, AND
RP   VARIANTS MTDPS4A ASP-767; HIS-879; SER-885; PRO-914; HIS-1096 AND ASN-1191.
RX   PubMed=16621917; DOI=10.1093/brain/awl088;
RA   Horvath R., Hudson G., Ferrari G., Fuetterer N., Ahola S., Lamantea E.,
RA   Prokisch H., Lochmueller H., McFarland R., Ramesh V., Klopstock T.,
RA   Freisinger P., Salvi F., Mayr J.A., Santer R., Tesarova M., Zeman J.,
RA   Udd B., Taylor R.W., Turnbull D., Hanna M., Fialho D., Suomalainen A.,
RA   Zeviani M., Chinnery P.F.;
RT   "Phenotypic spectrum associated with mutations of the mitochondrial
RT   polymerase gamma gene.";
RL   Brain 129:1674-1684(2006).
RN   [34]
RP   VARIANTS PEOB1 ARG-304; ASP-380 AND THR-467, VARIANT SANDO SER-748, VARIANT
RP   MTDPS4A PRO-914, AND VARIANTS GLY-1143 AND HIS-1236.
RX   PubMed=16639411; DOI=10.1038/sj.ejhg.5201627;
RA   Naiemi M., Bannwarth S., Procaccio V., Pouget J., Desnuelle C.,
RA   Pellissier J.-F., Roetig A., Munnich A., Calvas P., Richelme C.,
RA   Jonveaux P., Castelnovo G., Simon M., Clanet M., Wallace D.,
RA   Paquis-Flucklinger V.;
RT   "Molecular analysis of ANT1, TWINKLE and POLG in patients with multiple
RT   deletions or depletion of mitochondrial DNA by a dHPLC-based assay.";
RL   Eur. J. Hum. Genet. 14:917-922(2006).
RN   [35]
RP   ERRATUM OF PUBMED:16639411.
RA   Naiemi M., Bannwarth S., Procaccio V., Pouget J., Desnuelle C.,
RA   Pellissier J.-F., Roetig A., Munnich A., Calvas P., Richelme C.,
RA   Jonveaux P., Castelnovo G., Simon M., Clanet M., Wallace D.,
RA   Paquis-Flucklinger V.;
RL   Eur. J. Hum. Genet. 15:607-607(2006).
RN   [36]
RP   VARIANTS SANDO ARG-648 AND CYS-807.
RX   PubMed=16919951; DOI=10.1016/j.nmd.2006.05.016;
RA   Gago M.F., Rosas M.J., Guimaraes J., Ferreira M., Vilarinho L., Castro L.,
RA   Carpenter S.;
RT   "SANDO: two novel mutations in POLG1 gene.";
RL   Neuromuscul. Disord. 16:507-509(2006).
RN   [37]
RP   VARIANT PEOA1 ASN-511, AND VARIANT PHE-463.
RX   PubMed=17420318; DOI=10.1001/archneur.64.4.553;
RA   Hudson G., Schaefer A.M., Taylor R.W., Tiangyou W., Gibson A., Venables G.,
RA   Griffiths P., Burn D.J., Turnbull D.M., Chinnery P.F.;
RT   "Mutation of the linker region of the polymerase gamma-1 (POLG1) gene
RT   associated with progressive external ophthalmoplegia and Parkinsonism.";
RL   Arch. Neurol. 64:553-557(2007).
RN   [38]
RP   VARIANT PEOA1 CYS-831.
RX   PubMed=17846414; DOI=10.1212/01.wnl.0000276955.23735.eb;
RA   Luoma P.T., Eerola J., Ahola S., Hakonen A.H., Hellstroem O.,
RA   Kivistoe K.T., Tienari P.J., Suomalainen A.;
RT   "Mitochondrial DNA polymerase gamma variants in idiopathic sporadic
RT   Parkinson disease.";
RL   Neurology 69:1152-1159(2007).
RN   [39]
RP   VARIANT PEOA1 HIS-1186.
RX   PubMed=18575922; DOI=10.1007/s00415-008-0926-3;
RA   Virgilio R., Ronchi D., Hadjigeorgiou G.M., Bordoni A., Saladino F.,
RA   Moggio M., Adobbati L., Kafetsouli D., Tsironi E., Previtali S.,
RA   Papadimitriou A., Bresolin N., Comi G.P.;
RT   "Novel Twinkle (PEO1) gene mutations in Mendelian progressive external
RT   ophthalmoplegia.";
RL   J. Neurol. 255:1384-1391(2008).
RN   [40]
RP   VARIANTS LS HIS-232 AND SER-848, VARIANTS MTDPS4A ILE-251; THR-467;
RP   LEU-587; SER-748; CYS-831; SER-848; PRO-914; TYR-1110; ARG-1134 AND
RP   LYS-1136, AND VARIANTS GLY-1143 AND HIS-1236.
RX   PubMed=18828154; DOI=10.1002/humu.20852;
RA   Taanman J.-W., Rahman S., Pagnamenta A.T., Morris A.A.M.,
RA   Bitner-Glindzicz M., Wolf N.I., Leonard J.V., Clayton P.T.,
RA   Schapira A.H.V.;
RT   "Analysis of mutant DNA polymerase gamma in patients with mitochondrial DNA
RT   depletion.";
RL   Hum. Mutat. 30:248-254(2009).
RN   [41]
RP   VARIANTS MTDPS4B TRP-227 AND SER-848.
RX   PubMed=19307547; DOI=10.1212/01.wnl.0000345002.47396.e1;
RA   Giordano C., Powell H., Leopizzi M., de Curtis M., Travaglini C.,
RA   Sebastiani M., Gallo P., Taylor R.W., d'Amati G.;
RT   "Fatal congenital myopathy and gastrointestinal pseudo-obstruction due to
RT   POLG1 mutations.";
RL   Neurology 72:1103-1105(2009).
RN   [42]
RP   VARIANT MTDPS4A CYS-1096.
RX   PubMed=25129007; DOI=10.1007/s13312-014-0475-z;
RA   Bijarnia-Mahay S., Mohan N., Goyal D., Verma I.C.;
RT   "Mitochondrial DNA depletion syndrome causing liver failure.";
RL   Indian Pediatr. 51:666-668(2014).
CC   -!- FUNCTION: Involved in the replication of mitochondrial DNA. Associates
CC       with mitochondrial DNA.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2'-deoxyribonucleoside 5'-triphosphate + DNA(n) =
CC         diphosphate + DNA(n+1); Xref=Rhea:RHEA:22508, Rhea:RHEA-COMP:11130,
CC         Rhea:RHEA-COMP:11131, ChEBI:CHEBI:33019, ChEBI:CHEBI:61560,
CC         ChEBI:CHEBI:83828; EC=2.7.7.7;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- SUBUNIT: Heterotrimer composed of a catalytic subunit and a homodimer
CC       of accessory subunits (By similarity). Interacts with TTC3
CC       (PubMed:29290964). {ECO:0000250|UniProtKB:Q27607,
CC       ECO:0000269|PubMed:29290964}.
CC   -!- INTERACTION:
CC       P54098; Q9UHN1: POLG2; NbExp=11; IntAct=EBI-852624, EBI-852642;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:18063578}.
CC       Mitochondrion matrix, mitochondrion nucleoid
CC       {ECO:0000269|PubMed:18063578}.
CC   -!- POLYMORPHISM: The poly-Gln region seems to be polymorphic.
CC   -!- DISEASE: Progressive external ophthalmoplegia with mitochondrial DNA
CC       deletions, autosomal dominant, 1 (PEOA1) [MIM:157640]: A disorder
CC       characterized by progressive weakness of ocular muscles and levator
CC       muscle of the upper eyelid. In a minority of cases, it is associated
CC       with skeletal myopathy, which predominantly involves axial or proximal
CC       muscles and which causes abnormal fatigability and even permanent
CC       muscle weakness. Ragged-red fibers and atrophy are found on muscle
CC       biopsy. A large proportion of chronic ophthalmoplegias are associated
CC       with other symptoms, leading to a multisystemic pattern of this
CC       disease. Additional symptoms are variable, and may include cataracts,
CC       hearing loss, sensory axonal neuropathy, ataxia, depression,
CC       hypogonadism, and parkinsonism. {ECO:0000269|PubMed:11897778,
CC       ECO:0000269|PubMed:12210792, ECO:0000269|PubMed:15351195,
CC       ECO:0000269|PubMed:15534189, ECO:0000269|PubMed:17420318,
CC       ECO:0000269|PubMed:17846414, ECO:0000269|PubMed:18575922}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Progressive external ophthalmoplegia with mitochondrial DNA
CC       deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]: A severe form
CC       of progressive external ophthalmoplegia, a disorder characterized by
CC       progressive weakness of ocular muscles and levator muscle of the upper
CC       eyelid. It is clinically more heterogeneous than the autosomal dominant
CC       forms. {ECO:0000269|PubMed:11431686, ECO:0000269|PubMed:12565911,
CC       ECO:0000269|PubMed:12707443, ECO:0000269|PubMed:12872260,
CC       ECO:0000269|PubMed:12975295, ECO:0000269|PubMed:14635118,
CC       ECO:0000269|PubMed:15349879, ECO:0000269|PubMed:15351195,
CC       ECO:0000269|PubMed:15477547, ECO:0000269|PubMed:15917273,
CC       ECO:0000269|PubMed:16401742, ECO:0000269|PubMed:16621917,
CC       ECO:0000269|PubMed:16634032, ECO:0000269|PubMed:16639411}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Sensory ataxic neuropathy dysarthria and ophthalmoparesis
CC       (SANDO) [MIM:607459]: A systemic disorder resulting from mitochondrial
CC       dysfunction associated with mitochondrial depletion in skeletal muscle
CC       and peripheral nerve tissue. The clinical triad of symptoms consists of
CC       sensory ataxic neuropathy, dysarthria, and ophthalmoparesis. However,
CC       the phenotype varies widely, even within the same family, and can also
CC       include myopathy, seizures, and hearing loss.
CC       {ECO:0000269|PubMed:12565911, ECO:0000269|PubMed:14745080,
CC       ECO:0000269|PubMed:15477547, ECO:0000269|PubMed:15824347,
CC       ECO:0000269|PubMed:15917273, ECO:0000269|PubMed:16080118,
CC       ECO:0000269|PubMed:16621917, ECO:0000269|PubMed:16639411,
CC       ECO:0000269|PubMed:16919951}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Mitochondrial DNA depletion syndrome 4A (MTDPS4A)
CC       [MIM:203700]: An autosomal recessive hepatocerebral syndrome due to
CC       mitochondrial dysfunction. The typical course of the disease includes
CC       severe developmental delay, intractable seizures, liver failure, and
CC       death in childhood. Refractory seizures, cortical blindness,
CC       progressive liver dysfunction, and acute liver failure after exposure
CC       to valproic acid are considered diagnostic features. The
CC       neuropathological hallmarks are neuronal loss, spongiform degeneration,
CC       and astrocytosis of the visual cortex. Liver biopsy results show
CC       steatosis, often progressing to cirrhosis.
CC       {ECO:0000269|PubMed:15122711, ECO:0000269|PubMed:15689359,
CC       ECO:0000269|PubMed:15929042, ECO:0000269|PubMed:16621917,
CC       ECO:0000269|PubMed:16639411, ECO:0000269|PubMed:18828154,
CC       ECO:0000269|PubMed:25129007}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Mitochondrial DNA depletion syndrome 4B (MTDPS4B)
CC       [MIM:613662]: An autosomal recessive progressive multisystem disorder
CC       due to mitochondrial dysfunction. It is clinically characterized by
CC       chronic gastrointestinal dysmotility and pseudo-obstruction, cachexia,
CC       progressive external ophthalmoplegia, axonal sensory ataxic neuropathy,
CC       and muscle weakness. {ECO:0000269|PubMed:12825077,
CC       ECO:0000269|PubMed:19307547}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset progressive
CC       neurodegenerative disorder characterized by the presence of focal,
CC       bilateral lesions in one or more areas of the central nervous system
CC       including the brainstem, thalamus, basal ganglia, cerebellum and spinal
CC       cord. Clinical features depend on which areas of the central nervous
CC       system are involved and include subacute onset of psychomotor
CC       retardation, hypotonia, ataxia, weakness, vision loss, eye movement
CC       abnormalities, seizures, and dysphagia. {ECO:0000269|PubMed:18828154}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   -!- DISEASE: Spinocerebellar ataxia with epilepsy (SCAE) [MIM:607459]: An
CC       autosomal recessive syndrome characterized by headaches and/or seizures
CC       manifesting in childhood or adolescence, cerebellar and sensory ataxia,
CC       dysarthria, and myoclonus manifesting in early adulthood.
CC       Neuropathological findings include spinocerebellar degeneration
CC       associated with cortical neuronal degeneration in advanced cases.
CC       {ECO:0000269|PubMed:26942291}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the DNA polymerase type-A family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/polg/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U60325; AAC50712.1; -; mRNA.
DR   EMBL; X98093; CAA66719.1; -; mRNA.
DR   EMBL; D84103; BAA12223.1; -; mRNA.
DR   EMBL; AF497906; AAM77583.1; -; Genomic_DNA.
DR   EMBL; BC042571; AAH42571.1; -; mRNA.
DR   EMBL; BC050559; AAH50559.1; -; mRNA.
DR   CCDS; CCDS10350.1; -.
DR   PIR; G02750; G02750.
DR   RefSeq; NP_001119603.1; NM_001126131.1.
DR   RefSeq; NP_002684.1; NM_002693.2.
DR   PDB; 3IKM; X-ray; 3.24 A; A/D=70-1239.
DR   PDB; 4ZTU; X-ray; 3.30 A; A=30-1239.
DR   PDB; 4ZTZ; X-ray; 3.44 A; A=30-1239.
DR   PDB; 5C51; X-ray; 3.43 A; A=25-1239.
DR   PDB; 5C52; X-ray; 3.64 A; A=25-1239.
DR   PDB; 5C53; X-ray; 3.57 A; A=25-1239.
DR   PDBsum; 3IKM; -.
DR   PDBsum; 4ZTU; -.
DR   PDBsum; 4ZTZ; -.
DR   PDBsum; 5C51; -.
DR   PDBsum; 5C52; -.
DR   PDBsum; 5C53; -.
DR   SMR; P54098; -.
DR   BioGRID; 111424; 70.
DR   ComplexPortal; CPX-2093; Mitochondrial DNA polymerase gamma complex.
DR   IntAct; P54098; 25.
DR   MINT; P54098; -.
DR   STRING; 9606.ENSP00000268124; -.
DR   BindingDB; P54098; -.
DR   ChEMBL; CHEMBL2732; -.
DR   DrugCentral; P54098; -.
DR   iPTMnet; P54098; -.
DR   PhosphoSitePlus; P54098; -.
DR   BioMuta; POLG; -.
DR   DMDM; 1706507; -.
DR   EPD; P54098; -.
DR   jPOST; P54098; -.
DR   MassIVE; P54098; -.
DR   MaxQB; P54098; -.
DR   PaxDb; P54098; -.
DR   PeptideAtlas; P54098; -.
DR   PRIDE; P54098; -.
DR   ProteomicsDB; 56642; -.
DR   Antibodypedia; 28558; 214 antibodies.
DR   Ensembl; ENST00000268124; ENSP00000268124; ENSG00000140521.
DR   Ensembl; ENST00000442287; ENSP00000399851; ENSG00000140521.
DR   GeneID; 5428; -.
DR   KEGG; hsa:5428; -.
DR   UCSC; uc002bnr.5; human.
DR   CTD; 5428; -.
DR   DisGeNET; 5428; -.
DR   GeneCards; POLG; -.
DR   GeneReviews; POLG; -.
DR   HGNC; HGNC:9179; POLG.
DR   HPA; ENSG00000140521; Low tissue specificity.
DR   MalaCards; POLG; -.
DR   MIM; 157640; phenotype.
DR   MIM; 174763; gene.
DR   MIM; 203700; phenotype.
DR   MIM; 256000; phenotype.
DR   MIM; 258450; phenotype.
DR   MIM; 607459; phenotype.
DR   MIM; 613662; phenotype.
DR   neXtProt; NX_P54098; -.
DR   OpenTargets; ENSG00000140521; -.
DR   Orphanet; 726; Alpers-Huttenlocher syndrome.
DR   Orphanet; 254892; Autosomal dominant progressive external ophthalmoplegia.
DR   Orphanet; 254886; Autosomal recessive progressive external ophthalmoplegia.
DR   Orphanet; 298; Mitochondrial neurogastrointestinal encephalomyopathy.
DR   Orphanet; 402082; Progressive myoclonic epilepsy type 5.
DR   Orphanet; 94125; Recessive mitochondrial ataxia syndrome.
DR   Orphanet; 70595; Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome.
DR   Orphanet; 254881; Spinocerebellar ataxia with epilepsy.
DR   PharmGKB; PA33500; -.
DR   VEuPathDB; HostDB:ENSG00000140521.11; -.
DR   eggNOG; KOG3657; Eukaryota.
DR   GeneTree; ENSGT00390000000453; -.
DR   HOGENOM; CLU_001524_2_2_1; -.
DR   InParanoid; P54098; -.
DR   OMA; DTEVMWK; -.
DR   OrthoDB; 86850at2759; -.
DR   PhylomeDB; P54098; -.
DR   PathwayCommons; P54098; -.
DR   SIGNOR; P54098; -.
DR   BioGRID-ORCS; 5428; 193 hits in 998 CRISPR screens.
DR   ChiTaRS; POLG; human.
DR   GeneWiki; POLG; -.
DR   GenomeRNAi; 5428; -.
DR   Pharos; P54098; Tchem.
DR   PRO; PR:P54098; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; P54098; protein.
DR   Bgee; ENSG00000140521; Expressed in tendon of biceps brachii and 250 other tissues.
DR   ExpressionAtlas; P54098; baseline and differential.
DR   Genevisible; P54098; HS.
DR   GO; GO:0005760; C:gamma DNA polymerase complex; IDA:UniProtKB.
DR   GO; GO:0042645; C:mitochondrial nucleoid; IDA:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0032991; C:protein-containing complex; IDA:MGI.
DR   GO; GO:0043195; C:terminal bouton; IEA:Ensembl.
DR   GO; GO:0008408; F:3'-5' exonuclease activity; IDA:FlyBase.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; IDA:UniProtKB.
DR   GO; GO:0002020; F:protease binding; IPI:UniProtKB.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0006287; P:base-excision repair, gap-filling; IDA:MGI.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl.
DR   GO; GO:0006259; P:DNA metabolic process; TAS:ProtInc.
DR   GO; GO:0006261; P:DNA-dependent DNA replication; IDA:UniProtKB.
DR   GO; GO:0006264; P:mitochondrial DNA replication; IMP:UniProtKB.
DR   GO; GO:0010332; P:response to gamma radiation; IEA:Ensembl.
DR   GO; GO:0055093; P:response to hyperoxia; IEA:Ensembl.
DR   GO; GO:0009416; P:response to light stimulus; IEA:Ensembl.
DR   InterPro; IPR019760; DNA-dir_DNA_pol_A_CS.
DR   InterPro; IPR002297; DNA-dir_DNA_pol_A_mt.
DR   InterPro; IPR001098; DNA-dir_DNA_pol_A_palm_dom.
DR   InterPro; IPR043502; DNA/RNA_pol_sf.
DR   InterPro; IPR041336; DNApol_Exo.
DR   InterPro; IPR012337; RNaseH-like_sf.
DR   PANTHER; PTHR10267; PTHR10267; 1.
DR   Pfam; PF00476; DNA_pol_A; 1.
DR   Pfam; PF18136; DNApol_Exo; 1.
DR   PIRSF; PIRSF000797; DNA_pol_mt; 1.
DR   PRINTS; PR00867; DNAPOLG.
DR   SMART; SM00482; POLAc; 1.
DR   SUPFAM; SSF53098; SSF53098; 1.
DR   SUPFAM; SSF56672; SSF56672; 1.
DR   PROSITE; PS00447; DNA_POLYMERASE_A; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Disease variant; DNA replication; DNA-binding;
KW   DNA-directed DNA polymerase; Epilepsy; Leigh syndrome; Magnesium;
KW   Mitochondrion; Mitochondrion nucleoid; Neurodegeneration; Neuropathy;
KW   Nucleotidyltransferase; Primary mitochondrial disease;
KW   Progressive external ophthalmoplegia; Reference proteome; Transferase.
FT   CHAIN           1..1239
FT                   /note="DNA polymerase subunit gamma-1"
FT                   /id="PRO_0000101270"
FT   COMPBIAS        43..60
FT                   /note="Poly-Gln"
FT   COMPBIAS        535..538
FT                   /note="Poly-Glu"
FT   VARIANT         3
FT                   /note="R -> P (in PEOB1; dbSNP:rs121918045)"
FT                   /evidence="ECO:0000269|PubMed:11431686,
FT                   ECO:0000269|PubMed:12565911"
FT                   /id="VAR_012153"
FT   VARIANT         18
FT                   /note="P -> S (in dbSNP:rs3087373)"
FT                   /id="VAR_014904"
FT   VARIANT         55
FT                   /note="Q -> QQ"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_019265"
FT   VARIANT         55
FT                   /note="Q -> QQQ"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_019266"
FT   VARIANT         193
FT                   /note="R -> Q (in dbSNP:rs3176162)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_019267"
FT   VARIANT         227
FT                   /note="R -> W (in PEOB1 and MTDPS4B; dbSNP:rs121918056)"
FT                   /evidence="ECO:0000269|PubMed:12707443,
FT                   ECO:0000269|PubMed:15349879, ECO:0000269|PubMed:19307547"
FT                   /id="VAR_023663"
FT   VARIANT         232
FT                   /note="R -> G (in MTDPS4A)"
FT                   /evidence="ECO:0000269|PubMed:15689359"
FT                   /id="VAR_058870"
FT   VARIANT         232
FT                   /note="R -> H (in LS; dbSNP:rs113994093)"
FT                   /evidence="ECO:0000269|PubMed:18828154"
FT                   /id="VAR_058871"
FT   VARIANT         244
FT                   /note="L -> P (in MTDPS4A)"
FT                   /evidence="ECO:0000269|PubMed:15689359"
FT                   /id="VAR_058872"
FT   VARIANT         251
FT                   /note="T -> I (in PEOB1, MTDPS4A and MTDPS4B;
FT                   dbSNP:rs113994094)"
FT                   /evidence="ECO:0000269|PubMed:12210792,
FT                   ECO:0000269|PubMed:12707443, ECO:0000269|PubMed:12825077,
FT                   ECO:0000269|PubMed:14635118, ECO:0000269|PubMed:18828154,
FT                   ECO:0000269|PubMed:26942291"
FT                   /id="VAR_023664"
FT   VARIANT         268
FT                   /note="G -> A (in PEOB1; sporadic case; dbSNP:rs61752784)"
FT                   /evidence="ECO:0000269|PubMed:14635118"
FT                   /id="VAR_058873"
FT   VARIANT         304
FT                   /note="L -> R (in PEOB1; also found in SANDO;
FT                   dbSNP:rs121918044)"
FT                   /evidence="ECO:0000269|PubMed:11431686,
FT                   ECO:0000269|PubMed:12565911, ECO:0000269|PubMed:16639411"
FT                   /id="VAR_012154"
FT   VARIANT         304
FT                   /note="L -> SANDO (in PEOB1)"
FT                   /id="VAR_058874"
FT   VARIANT         308
FT                   /note="Q -> H (in PEOB1; sporadic case; dbSNP:rs745539599)"
FT                   /evidence="ECO:0000269|PubMed:16621917"
FT                   /id="VAR_058875"
FT   VARIANT         309
FT                   /note="R -> L (in PEOB1)"
FT                   /evidence="ECO:0000269|PubMed:12210792,
FT                   ECO:0000269|PubMed:15349879"
FT                   /id="VAR_023665"
FT   VARIANT         312
FT                   /note="W -> R (in PEOB1; sporadic case)"
FT                   /evidence="ECO:0000269|PubMed:12707443,
FT                   ECO:0000269|PubMed:14635118"
FT                   /id="VAR_023666"
FT   VARIANT         324
FT                   /note="P -> S (in dbSNP:rs2307437)"
FT                   /id="VAR_014905"
FT   VARIANT         380
FT                   /note="G -> D (in PEOB1)"
FT                   /evidence="ECO:0000269|PubMed:16639411"
FT                   /id="VAR_058876"
FT   VARIANT         431
FT                   /note="G -> V (in PEOB1; sporadic case)"
FT                   /evidence="ECO:0000269|PubMed:12707443"
FT                   /id="VAR_023667"
FT   VARIANT         463
FT                   /note="L -> F (in dbSNP:rs150828914)"
FT                   /evidence="ECO:0000269|PubMed:17420318"
FT                   /id="VAR_058877"
FT   VARIANT         467
FT                   /note="A -> T (in PEOB1, SANDO, SCAE and MTDPS4A; results
FT                   in clearly decreased activity, DNA binding and processivity
FT                   of the polymerase; dbSNP:rs113994095)"
FT                   /evidence="ECO:0000269|PubMed:11431686,
FT                   ECO:0000269|PubMed:12565911, ECO:0000269|PubMed:12707443,
FT                   ECO:0000269|PubMed:14635118, ECO:0000269|PubMed:14694057,
FT                   ECO:0000269|PubMed:15122711, ECO:0000269|PubMed:15477547,
FT                   ECO:0000269|PubMed:15689359, ECO:0000269|PubMed:15824347,
FT                   ECO:0000269|PubMed:15917273, ECO:0000269|PubMed:16639411,
FT                   ECO:0000269|PubMed:18828154, ECO:0000269|PubMed:26942291"
FT                   /id="VAR_012155"
FT   VARIANT         468
FT                   /note="N -> D (in PEOB1; dbSNP:rs145843073)"
FT                   /evidence="ECO:0000269|PubMed:15351195"
FT                   /id="VAR_023668"
FT   VARIANT         497
FT                   /note="Q -> H (in SANDO and SCAE; dbSNP:rs121918052)"
FT                   /evidence="ECO:0000269|PubMed:15824347,
FT                   ECO:0000269|PubMed:26942291"
FT                   /id="VAR_023669"
FT   VARIANT         511
FT                   /note="S -> N (in PEOA1; dbSNP:rs121918055)"
FT                   /evidence="ECO:0000269|PubMed:17420318"
FT                   /id="VAR_058878"
FT   VARIANT         517
FT                   /note="G -> V (in SANDO; dbSNP:rs61752783)"
FT                   /evidence="ECO:0000269|PubMed:16621917"
FT                   /id="VAR_058879"
FT   VARIANT         546
FT                   /note="R -> C (in dbSNP:rs2307447)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_014906"
FT   VARIANT         562
FT                   /note="R -> Q (in PEOB1; sporadic case; dbSNP:rs781168350)"
FT                   /evidence="ECO:0000269|PubMed:14635118"
FT                   /id="VAR_058880"
FT   VARIANT         574
FT                   /note="R -> W (in PEOB1; sporadic case; dbSNP:rs774474723)"
FT                   /evidence="ECO:0000269|PubMed:16621917"
FT                   /id="VAR_058881"
FT   VARIANT         579
FT                   /note="R -> W (in PEOB1; dbSNP:rs556925652)"
FT                   /evidence="ECO:0000269|PubMed:12975295"
FT                   /id="VAR_023670"
FT   VARIANT         587
FT                   /note="P -> L (in PEOB1, MTDPS4A and MTDPS4B;
FT                   dbSNP:rs113994096)"
FT                   /evidence="ECO:0000269|PubMed:12825077,
FT                   ECO:0000269|PubMed:12975295, ECO:0000269|PubMed:14635118,
FT                   ECO:0000269|PubMed:15349879, ECO:0000269|PubMed:15689359,
FT                   ECO:0000269|PubMed:18828154"
FT                   /id="VAR_023671"
FT   VARIANT         603
FT                   /note="M -> L (in PEOB1)"
FT                   /evidence="ECO:0000269|PubMed:16401742"
FT                   /id="VAR_058882"
FT   VARIANT         627
FT                   /note="R -> Q (in SANDO; shows DNA binding affinity and
FT                   processivities similar to the controls; dbSNP:rs375305567)"
FT                   /evidence="ECO:0000269|PubMed:15917273"
FT                   /id="VAR_058883"
FT   VARIANT         627
FT                   /note="R -> W (in SANDO; sporadic case; dbSNP:rs121918046)"
FT                   /evidence="ECO:0000269|PubMed:12565911"
FT                   /id="VAR_023672"
FT   VARIANT         648
FT                   /note="P -> R (in PEOB1; sporadic case; also in SANDO;
FT                   dbSNP:rs796052906)"
FT                   /evidence="ECO:0000269|PubMed:16621917,
FT                   ECO:0000269|PubMed:16919951"
FT                   /id="VAR_058884"
FT   VARIANT         662
FT                   /note="E -> K (in dbSNP:rs2307450)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_014907"
FT   VARIANT         737
FT                   /note="G -> R (in PEOB1; with absence of progressive
FT                   external ophthalmoplegia; dbSNP:rs121918054)"
FT                   /evidence="ECO:0000269|PubMed:16634032"
FT                   /id="VAR_058885"
FT   VARIANT         748
FT                   /note="W -> S (in SANDO, SCAE and MTDPS4A; unknown
FT                   pathological significance; dbSNP:rs113994097)"
FT                   /evidence="ECO:0000269|PubMed:15477547,
FT                   ECO:0000269|PubMed:15824347, ECO:0000269|PubMed:15929042,
FT                   ECO:0000269|PubMed:16080118, ECO:0000269|PubMed:16639411,
FT                   ECO:0000269|PubMed:18828154"
FT                   /id="VAR_023673"
FT   VARIANT         767
FT                   /note="A -> D (in MTDPS4A)"
FT                   /evidence="ECO:0000269|PubMed:16621917"
FT                   /id="VAR_058886"
FT   VARIANT         807
FT                   /note="R -> C (in SANDO; dbSNP:rs769827124)"
FT                   /evidence="ECO:0000269|PubMed:16919951"
FT                   /id="VAR_058887"
FT   VARIANT         807
FT                   /note="R -> P (in PEOB1; sporadic case)"
FT                   /evidence="ECO:0000269|PubMed:14635118"
FT                   /id="VAR_058888"
FT   VARIANT         831
FT                   /note="Y -> C (in PEOA1 and MTDPS4A; unknown pathological
FT                   significance; dbSNP:rs41549716)"
FT                   /evidence="ECO:0000269|PubMed:15534189,
FT                   ECO:0000269|PubMed:17846414, ECO:0000269|PubMed:18828154"
FT                   /id="VAR_023674"
FT   VARIANT         848
FT                   /note="G -> S (in PEOB1, MTDPS4A, MTDPS4B and LS;
FT                   dbSNP:rs113994098)"
FT                   /evidence="ECO:0000269|PubMed:12210792,
FT                   ECO:0000269|PubMed:12872260, ECO:0000269|PubMed:15689359,
FT                   ECO:0000269|PubMed:15929042, ECO:0000269|PubMed:18828154,
FT                   ECO:0000269|PubMed:19307547"
FT                   /id="VAR_023675"
FT   VARIANT         853
FT                   /note="R -> W (in PEOB1; with absence of progressive
FT                   external ophthalmoplegia; dbSNP:rs121918053)"
FT                   /evidence="ECO:0000269|PubMed:16401742,
FT                   ECO:0000269|PubMed:16634032"
FT                   /id="VAR_058889"
FT   VARIANT         864
FT                   /note="N -> S (in MTDPS4B; dbSNP:rs121918050)"
FT                   /evidence="ECO:0000269|PubMed:12825077"
FT                   /id="VAR_023676"
FT   VARIANT         879
FT                   /note="Q -> H (in MTDPS4A)"
FT                   /evidence="ECO:0000269|PubMed:16621917"
FT                   /id="VAR_058890"
FT   VARIANT         885
FT                   /note="T -> S (in MTDPS4A)"
FT                   /evidence="ECO:0000269|PubMed:16621917"
FT                   /id="VAR_058891"
FT   VARIANT         889
FT                   /note="A -> T (in PEOB1; dbSNP:rs763393580)"
FT                   /evidence="ECO:0000269|PubMed:12975295"
FT                   /id="VAR_023677"
FT   VARIANT         914
FT                   /note="T -> P (in MTDPS4A; dbSNP:rs139590686)"
FT                   /evidence="ECO:0000269|PubMed:16621917,
FT                   ECO:0000269|PubMed:16639411, ECO:0000269|PubMed:18828154"
FT                   /id="VAR_058892"
FT   VARIANT         923
FT                   /note="G -> D (in PEOA1)"
FT                   /evidence="ECO:0000269|PubMed:12210792"
FT                   /id="VAR_023678"
FT   VARIANT         932
FT                   /note="H -> Y (in SANDO and PEOB1; sporadic case;
FT                   dbSNP:rs121918048)"
FT                   /evidence="ECO:0000269|PubMed:14635118,
FT                   ECO:0000269|PubMed:14745080"
FT                   /id="VAR_023679"
FT   VARIANT         943
FT                   /note="R -> H (in PEOA1)"
FT                   /evidence="ECO:0000269|PubMed:12210792"
FT                   /id="VAR_023680"
FT   VARIANT         953
FT                   /note="R -> C (in PEOA1; dbSNP:rs11546842)"
FT                   /evidence="ECO:0000269|PubMed:15351195"
FT                   /id="VAR_023681"
FT   VARIANT         955
FT                   /note="Y -> C (in PEOA1; can underlie parkinsonism; 45-fold
FT                   decrease in apparent binding affinity for the incoming
FT                   nucleoside triphosphate; 2-fold less accurate for basepair
FT                   substitutions than wild-type; dbSNP:rs113994099)"
FT                   /evidence="ECO:0000269|PubMed:11431686,
FT                   ECO:0000269|PubMed:11897778, ECO:0000269|PubMed:12210792,
FT                   ECO:0000269|PubMed:12565911, ECO:0000269|PubMed:15351195"
FT                   /id="VAR_012156"
FT   VARIANT         957
FT                   /note="A -> P (in MTDPS4A)"
FT                   /evidence="ECO:0000269|PubMed:15689359"
FT                   /id="VAR_058893"
FT   VARIANT         957
FT                   /note="A -> S (in PEOA1; dbSNP:rs121918051)"
FT                   /evidence="ECO:0000269|PubMed:12210792"
FT                   /id="VAR_023682"
FT   VARIANT         1047
FT                   /note="R -> Q (in PEOB1; sporadic case; dbSNP:rs768028281)"
FT                   /evidence="ECO:0000269|PubMed:12707443"
FT                   /id="VAR_023683"
FT   VARIANT         1051
FT                   /note="G -> R (in SANDO; dbSNP:rs121918049)"
FT                   /evidence="ECO:0000269|PubMed:14745080"
FT                   /id="VAR_023684"
FT   VARIANT         1076
FT                   /note="G -> V (in PEOB1)"
FT                   /evidence="ECO:0000269|PubMed:12975295"
FT                   /id="VAR_023685"
FT   VARIANT         1096
FT                   /note="R -> C (in PEOB1 and MTDPS4A; dbSNP:rs201732356)"
FT                   /evidence="ECO:0000269|PubMed:12707443,
FT                   ECO:0000269|PubMed:25129007"
FT                   /id="VAR_023686"
FT   VARIANT         1096
FT                   /note="R -> H (in MTDPS4A; dbSNP:rs368435864)"
FT                   /evidence="ECO:0000269|PubMed:16621917"
FT                   /id="VAR_058894"
FT   VARIANT         1104
FT                   /note="S -> C (in PEOB1; sporadic case;
FT                   dbSNP:rs1010372555)"
FT                   /evidence="ECO:0000269|PubMed:12707443"
FT                   /id="VAR_023687"
FT   VARIANT         1105
FT                   /note="A -> T (in PEOB1; dbSNP:rs753410045)"
FT                   /evidence="ECO:0000269|PubMed:15351195"
FT                   /id="VAR_023688"
FT   VARIANT         1106
FT                   /note="V -> I (in PEOB1)"
FT                   /evidence="ECO:0000269|PubMed:15349879"
FT                   /id="VAR_023689"
FT   VARIANT         1110
FT                   /note="H -> Y (in MTDPS4A)"
FT                   /evidence="ECO:0000269|PubMed:18828154"
FT                   /id="VAR_058895"
FT   VARIANT         1134
FT                   /note="H -> R (in MTDPS4A)"
FT                   /evidence="ECO:0000269|PubMed:18828154"
FT                   /id="VAR_058896"
FT   VARIANT         1136
FT                   /note="E -> K (in MTDPS4A; dbSNP:rs56047213)"
FT                   /evidence="ECO:0000269|PubMed:18828154"
FT                   /id="VAR_065092"
FT   VARIANT         1142
FT                   /note="R -> W (in dbSNP:rs2307442)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_014908"
FT   VARIANT         1143
FT                   /note="E -> G (in dbSNP:rs2307441)"
FT                   /evidence="ECO:0000269|PubMed:14635118,
FT                   ECO:0000269|PubMed:15477547, ECO:0000269|PubMed:15689359,
FT                   ECO:0000269|PubMed:16080118, ECO:0000269|PubMed:16639411,
FT                   ECO:0000269|PubMed:18828154, ECO:0000269|Ref.4"
FT                   /id="VAR_014909"
FT   VARIANT         1146
FT                   /note="R -> C (in PEOB1; unknown pathological significance;
FT                   dbSNP:rs2307440)"
FT                   /evidence="ECO:0000269|PubMed:16401742, ECO:0000269|Ref.4"
FT                   /id="VAR_014910"
FT   VARIANT         1176
FT                   /note="S -> L (in PEOA1; dbSNP:rs776031396)"
FT                   /evidence="ECO:0000269|PubMed:12210792,
FT                   ECO:0000269|PubMed:15349879"
FT                   /id="VAR_023690"
FT   VARIANT         1184
FT                   /note="D -> N (in PEOB1; dbSNP:rs1131691575)"
FT                   /evidence="ECO:0000269|PubMed:16401742"
FT                   /id="VAR_058897"
FT   VARIANT         1186
FT                   /note="D -> H (in PEOA1)"
FT                   /evidence="ECO:0000269|PubMed:18575922"
FT                   /id="VAR_065119"
FT   VARIANT         1191
FT                   /note="K -> N (in MTDPS4A; dbSNP:rs1085307741)"
FT                   /evidence="ECO:0000269|PubMed:16621917"
FT                   /id="VAR_058898"
FT   VARIANT         1236
FT                   /note="Q -> H (in dbSNP:rs3087374)"
FT                   /evidence="ECO:0000269|PubMed:12975295,
FT                   ECO:0000269|PubMed:14635118, ECO:0000269|PubMed:15917273,
FT                   ECO:0000269|PubMed:16639411, ECO:0000269|PubMed:18828154,
FT                   ECO:0000269|Ref.4"
FT                   /id="VAR_014911"
FT   STRAND          75..77
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           83..86
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           97..105
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   TURN            106..111
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          114..116
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          132..134
FT                   /evidence="ECO:0007744|PDB:5C51"
FT   HELIX           135..159
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          173..178
FT                   /evidence="ECO:0007744|PDB:4ZTU"
FT   STRAND          179..181
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          184..189
FT                   /evidence="ECO:0007744|PDB:4ZTU"
FT   STRAND          192..195
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          198..201
FT                   /evidence="ECO:0007744|PDB:4ZTU"
FT   HELIX           203..205
FT                   /evidence="ECO:0007744|PDB:4ZTU"
FT   STRAND          207..210
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           224..227
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          235..237
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          240..242
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   TURN            243..247
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           248..251
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          254..256
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          260..262
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          265..268
FT                   /evidence="ECO:0007744|PDB:4ZTU"
FT   STRAND          271..274
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           277..279
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          282..285
FT                   /evidence="ECO:0007744|PDB:4ZTU"
FT   STRAND          290..293
FT                   /evidence="ECO:0007744|PDB:4ZTU"
FT   HELIX           296..301
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           306..317
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           347..349
FT                   /evidence="ECO:0007744|PDB:4ZTU"
FT   HELIX           356..360
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          373..376
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   TURN            377..380
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           385..415
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           422..431
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          435..438
FT                   /evidence="ECO:0007744|PDB:4ZTU"
FT   HELIX           440..473
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           478..480
FT                   /evidence="ECO:0007744|PDB:4ZTU"
FT   HELIX           483..490
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          503..505
FT                   /evidence="ECO:0007744|PDB:5C51"
FT   STRAND          519..521
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          537..540
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           541..558
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          559..561
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          563..568
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           571..575
FT                   /evidence="ECO:0007744|PDB:4ZTU"
FT   STRAND          587..589
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   TURN            592..595
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   TURN            597..604
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          607..610
FT                   /evidence="ECO:0007744|PDB:4ZTU"
FT   STRAND          616..618
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          627..629
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           636..644
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           647..671
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           716..721
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   TURN            738..740
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          743..745
FT                   /evidence="ECO:0007744|PDB:4ZTU"
FT   TURN            755..757
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           770..775
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          776..778
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          784..786
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           787..810
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          818..821
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   TURN            822..829
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          833..835
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          837..840
FT                   /evidence="ECO:0007744|PDB:4ZTU"
FT   STRAND          845..848
FT                   /evidence="ECO:0007744|PDB:4ZTU"
FT   TURN            849..851
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          853..855
FT                   /evidence="ECO:0007744|PDB:4ZTU"
FT   HELIX           859..861
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          867..869
FT                   /evidence="ECO:0007744|PDB:4ZTU"
FT   TURN            870..873
FT                   /evidence="ECO:0007744|PDB:4ZTU"
FT   HELIX           875..878
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          884..890
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           894..906
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          907..909
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   TURN            914..919
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   TURN            924..926
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           929..937
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           944..955
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           960..969
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           974..990
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          992..995
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          997..999
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           1001..1009
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          1010..1013
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           1027..1030
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          1033..1035
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           1037..1040
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   TURN            1041..1046
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           1047..1058
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          1061..1065
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          1068..1070
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   TURN            1073..1075
FT                   /evidence="ECO:0007744|PDB:5C51"
FT   TURN            1081..1083
FT                   /evidence="ECO:0007744|PDB:4ZTU"
FT   HELIX           1093..1121
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          1122..1124
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          1130..1133
FT                   /evidence="ECO:0007744|PDB:4ZTU"
FT   STRAND          1136..1143
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           1146..1168
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           1175..1178
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          1184..1188
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           1193..1195
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          1200..1203
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          1207..1209
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   HELIX           1220..1227
FT                   /evidence="ECO:0007744|PDB:3IKM"
FT   STRAND          1232..1235
FT                   /evidence="ECO:0007744|PDB:3IKM"
SQ   SEQUENCE   1239 AA;  139562 MW;  2D9ECCD75AD6E01E CRC64;
     MSRLLWRKVA GATVGPGPVP APGRWVSSSV PASDPSDGQR RRQQQQQQQQ QQQQQPQQPQ
     VLSSEGGQLR HNPLDIQMLS RGLHEQIFGQ GGEMPGEAAV RRSVEHLQKH GLWGQPAVPL
     PDVELRLPPL YGDNLDQHFR LLAQKQSLPY LEAANLLLQA QLPPKPPAWA WAEGWTRYGP
     EGEAVPVAIP EERALVFDVE VCLAEGTCPT LAVAISPSAW YSWCSQRLVE ERYSWTSQLS
     PADLIPLEVP TGASSPTQRD WQEQLVVGHN VSFDRAHIRE QYLIQGSRMR FLDTMSMHMA
     ISGLSSFQRS LWIAAKQGKH KVQPPTKQGQ KSQRKARRGP AISSWDWLDI SSVNSLAEVH
     RLYVGGPPLE KEPRELFVKG TMKDIRENFQ DLMQYCAQDV WATHEVFQQQ LPLFLERCPH
     PVTLAGMLEM GVSYLPVNQN WERYLAEAQG TYEELQREMK KSLMDLANDA CQLLSGERYK
     EDPWLWDLEW DLQEFKQKKA KKVKKEPATA SKLPIEGAGA PGDPMDQEDL GPCSEEEEFQ
     QDVMARACLQ KLKGTTELLP KRPQHLPGHP GWYRKLCPRL DDPAWTPGPS LLSLQMRVTP
     KLMALTWDGF PLHYSERHGW GYLVPGRRDN LAKLPTGTTL ESAGVVCPYR AIESLYRKHC
     LEQGKQQLMP QEAGLAEEFL LTDNSAIWQT VEELDYLEVE AEAKMENLRA AVPGQPLALT
     ARGGPKDTQP SYHHGNGPYN DVDIPGCWFF KLPHKDGNSC NVGSPFAKDF LPKMEDGTLQ
     AGPGGASGPR ALEINKMISF WRNAHKRISS QMVVWLPRSA LPRAVIRHPD YDEEGLYGAI
     LPQVVTAGTI TRRAVEPTWL TASNARPDRV GSELKAMVQA PPGYTLVGAD VDSQELWIAA
     VLGDAHFAGM HGCTAFGWMT LQGRKSRGTD LHSKTATTVG ISREHAKIFN YGRIYGAGQP
     FAERLLMQFN HRLTQQEAAE KAQQMYAATK GLRWYRLSDE GEWLVRELNL PVDRTEGGWI
     SLQDLRKVQR ETARKSQWKK WEVVAERAWK GGTESEMFNK LESIATSDIP RTPVLGCCIS
     RALEPSAVQE EFMTSRVNWV VQSSAVDYLH LMLVAMKWLF EEFAIDGRFC ISIHDEVRYL
     VREEDRYRAA LALQITNLLT RCMFAYKLGL NDLPQSVAFF SAVDIDRCLR KEVTMDCKTP
     SNPTGMERRY GIPQGEALDI YQIIELTKGS LEKRSQPGP
//
